Related references
Note: Only part of the references are listed.CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?
Dan G. Duda et al.
CLINICAL CANCER RESEARCH (2011)
The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs
Robert R. Langley et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Local treatment of metastatic cancer-killing the seed or disturbing the soil?
Scott C. Morgan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
James E. Talmadge et al.
CANCER RESEARCH (2010)
Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth
Dalit Barkan et al.
EUROPEAN JOURNAL OF CANCER (2010)
A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer (vol 155, pg 231, 2009)
Eugene H. Huang et al.
JOURNAL OF SURGICAL RESEARCH (2010)
A Role for Fibrillar Collagen Deposition and the Collagen Internalization Receptor Endo180 in Glioma Invasion
Ivo J. Huijbers et al.
PLOS ONE (2010)
Examining the Metastatic Niche: Targeting the Microenvironment
Theresa Guise
SEMINARS IN ONCOLOGY (2010)
The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers
Herve Wallerand et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1α, CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer
Lei Xu et al.
CANCER RESEARCH (2009)
A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer
Eugene H. Huang et al.
JOURNAL OF SURGICAL RESEARCH (2009)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
Transforming growth factor-β in breast cancer: too much, too late
Mary Helen Barcellos-Hoff et al.
BREAST CANCER RESEARCH (2009)
Metastatic cancer cell
Marina Bacac et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo
Sara Gosk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2008)
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice
M. A. Pantaleo et al.
BRITISH JOURNAL OF CANCER (2008)
Stephen Paget and the 'seed and soil' theory of metastatic dissemination
D. Ribatti et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2006)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
Tumor metastasis: mechanistic insights and clinical challenges
Patricia S. Steeg
NATURE MEDICINE (2006)
Astrocyte-endothelial interactions at the blood-brain barrier
NJ Abbott et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Breast cancer metastasis to bone: Mechanisms of osteolysis and implications for therapy
W Kozlow et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2005)
Targeting TGFβ signaling for cancer therapy
S Iyer et al.
CANCER BIOLOGY & THERAPY (2005)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies
RJ Epstein
NATURE REVIEWS CANCER (2004)
Allelic diversity in the host genetic background may be an important determinant in tumor metastatic dissemination
KW Hunter
CANCER LETTERS (2003)
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer
MA Cobleigh et al.
SEMINARS IN ONCOLOGY (2003)
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
JC Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
Genetic background is an important determinant of metastatic potential
K Hunter et al.
NATURE GENETICS (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Dissemination and growth of cancer cells in metastatic sites
AF Chambers et al.
NATURE REVIEWS CANCER (2002)
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
D Gancberg et al.
ANNALS OF ONCOLOGY (2002)
Astrocyte-endothelial interactions and blood-brain barrier permeability
NJ Abbott
JOURNAL OF ANATOMY (2002)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
Genomic analysis of metastasis reveals an essential role for RhoC
EA Clark et al.
NATURE (2000)
Share Paper
